References
- Waring GO, Rodrigues MM, Laibson PR. Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol. 1975;20(1):3–27. doi:10.1016/0039-6257(75)90034-X.
- Kenyon KR. Mesenchymal dysgenesis in Peters’ anomaly, sclerocornea and congenital endothelial dystrophy. Exp Eye Res. 1975;21(2):125–142. doi:10.1016/0014-4835(75)90077-9.
- Haddad AM, Greenfield DS, Stegman Z, Liebmann JM, Ritch R. Peter’s anomaly: diagnosis by ultrasound biomicroscopy. Ophthalmic Surg Lasers. 1997;28(4):311–312. doi:10.3928/1542-8877-19970401-09.
- Nischal KK. Congenital corneal opacities - a surgical approach to nomenclature and classification. Eye Lond Engl. 2007;21:1326–1337.
- Rezende RA, Uchoa UBC, Uchoa R, Rapuano CJ, Laibson PR, Cohen EJ. Congenital corneal opacities in a cornea referral practice. Cornea. 2004;23(6):565–570. doi:10.1097/01.ico.0000126317.90271.d8.
- Shigeyasu C, Yamada M, Mizuno Y, Yokoi T, Nishina S, Azuma N. Clinical features of anterior segment dysgenesis associated with congenital corneal opacities. Cornea. 2012;31(3):293–298. doi:10.1097/ICO.0b013e31820cd2ab.
- Karadag R, Rapuano CJ, Hammersmith KM, Nagra PK. Causes of congenital corneal opacities and their management in a tertiary care center. Arq Bras Oftalmol. 2020;83(2):98–102. doi:10.5935/0004-2749.20200023.
- Nischal KK, Naor J, Jay V, MacKeen LD, Rootman DS. Clinicopathological correlation of congenital corneal opacification using ultrasound biomicroscopy. Br J Ophthalmol. 2002;86(1):62–69. doi:10.1136/bjo.86.1.62.
- Matsubara A, Ozeki H, Matsunaga N, et al. Histopathological examination of two cases of anterior staphyloma associated with Peters’ anomaly and persistent hyperplastic primary vitreous. Br J Ophthalmol. 2001;85(12):1421–1425. doi:10.1136/bjo.85.12.1421.
- Stone DL, Kenyon KR, Green WR, Ryan SJ. Congenital central corneal leukoma (Peters’ anomaly). Am J Ophthalmol. 1976;81(2):173–193. doi:10.1016/0002-9394(76)90729-7.
- Holmström GE, Reardon WP, Baraitser M, Elston JS, Taylor DS. Heterogeneity in dominant anterior segment malformations. Br J Ophthalmol. 1991;75(10):591–597. doi:10.1136/bjo.75.10.591.
- Demir GÜ, Lafcı NG, Doğan ÖA, Şimşek-Kiper PÖ, Utine GE. Peters Plus syndrome: a recognizable clinical entity. Turk J Pediatr. 2020;62(1):136–140. doi:10.24953/turkjped.2020.01.020.
- Hanson IM, Fletcher JM, Jordan T, et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters’ anomaly. Nat Genet. 1994;6(2):168–173. doi:10.1038/ng0294-168.
- Doward W, Perveen R, Lloyd IC, Ridgway AEA, Wilson L, Black GCM. A mutation in the RIEG1 gene associated with Peters’ anomaly. J Med Genet. 1999;36(2):152–155. doi:10.1136/jmg.36.2.152.
- Honkanen RA, Nishimura DY, Swiderski RE, et al. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene. Am J Ophthalmol. 2003;135(3):368–375. doi:10.1016/S0002-9394(02)02061-5.
- Vincent A, Billingsley G, Priston M, et al. Further support of the role of CYP1B1 in patients with Peters anomaly. Mol Vis. 2006;12:506–510.
- Churchill AJ, Booth AP, Anwar R, Markham AF. PAX 6 is normal in most cases of Peters’ anomaly. Eye Lond Engl. 1998;12:299–303.
- Mataftsi A, Islam L, Kelberman D, Sowden JC, Nischal KK. Chromosome abnormalities and the genetics of congenital corneal opacification. Mol Vis. 2011;17:1624–1640.
- Ali M, Buentello-Volante B, McKibbin M, et al. Homozygous FOXE3 mutations cause non-syndromic, bilateral, total sclerocornea, aphakia, microphthalmia and optic disc coloboma. Mol Vis. 2010;16:1162–1168.
- Iseri SU, Osborne RJ, Farrall M, et al. Seeing clearly: the dominant and recessive nature of FOXE3 in eye developmental anomalies. Hum Mutat. 2009;30(10):1378–1386. doi:10.1002/humu.21079.
- Reis LM, Tyler RC, Abdul-Rahman O, et al. Mutation analysis of B3GALTL in Peters Plus syndrome. Am J Med Genet A. 2008;146A(20):2603–2610. doi:10.1002/ajmg.a.32498.
- Weh E, Reis LM, Tyler RC, et al. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes. Clin Genet. 2014;86(2):142–148. doi:10.1111/cge.12241.
- Harissi-Dagher M, Colby K. Anterior segment dysgenesis: peters anomaly and sclerocornea. Int Ophthalmol Clin. 2008;48(2):35–42. doi:10.1097/IIO.0b013e318169526c.
- Townsend WM, Font RL, Zimmerman LE. Congenital corneal leukomas. 2. Histopathologic findings in 19 eyes with central defect in Descemet’s membrane. Am J Ophthalmol. 1974;77(2):192–206. doi:10.1016/0002-9394(74)90673-4.
- Heon E, Barsoum-Homsy M, Cevrette L, et al. Peters’ anomaly. The spectrum of associated ocular and systemic malformations. Ophthalm Paediatr Genet. 1992;13(2):137–143. doi:10.3109/13816819209087614.
- Traboulsi EI, Maumenee IH. Peters’ anomaly and associated congenital malformations. Arch Ophthalmol. 1992;110(12):1739–1742. doi:10.1001/archopht.1992.01080240079035.
- Van Schooneveld MJ, Delleman JW, Beemer FA, Bleeker-Wagemakerp EM. Peters’-Plus: a new syndrome. Ophthalm Paediatr Genet. 1984;4(3):141–145. doi:10.3109/13816818409006113.
- Ozeki H, Shirai S, Nozaki M, et al. Ocular and systemic features of Peters’ anomaly. Graefes Arch Clin Exp Ophthalmol. 2000;238(10):833–839. doi:10.1007/s004170000177.
- Chang R-Q, Du Y, Zhu X-J, Lu Y. Type II Peter’s anomaly with histopathological proof: a case report. BMC Ophthalmol. 2017;17(1):110. doi:10.1186/s12886-017-0502-7.
- Shirai K, Okada Y, Nakamura Y, Saika S. Histopathological features in a case of peters’ anomaly with acquired corneal staphyloma. Case Rep Ophthalmol Med. 2011;2011:418048. doi:10.1155/2011/418048.
- Ni W, Wang W, Hong J, Zhang P, Liu C. A novel histopathologic finding in the Descemet’s membrane of a patient with Peters Anomaly: a case-report and literature review. BMC Ophthalmol. 2015;15(1):139. doi:10.1186/s12886-015-0131-y.
- Alkatan HM, Al Dhaheri H, Al Harby M. Terminology of Peters’ anomaly variants: summary of histopathological findings in 6 corneas and detailed clinicopathological correlation in 2 cases. Saudi J Ophthalmol. 2019;33(3):277–282. doi:10.1016/j.sjopt.2018.02.015.
- Fukuda S, Kawana K, Yasuno Y, Oshika T. Anterior ocular biometry using 3-dimensional optical coherence tomography. Ophthalmology. 2009;116(5):882–889. doi:10.1016/j.ophtha.2008.12.022.
- Doors M, Berendschot JM, de Brabander J, Webers CAB, Nuijts RM. Value of optical coherence tomography for anterior segment surgery. J Cataract Refract Surg. 2010;36(7):1213–1229. doi:10.1016/j.jcrs.2010.05.002.
- Alexander JL, Wei L, Palmer J, et al. A systematic review of ultrasound biomicroscopy use in pediatric ophthalmology. Eye Lond Engl. 2021;35(1):265–276.
- Pavlin CJ, Harasiewicz K, Sherar MD, Foster FS. Clinical use of ultrasound biomicroscopy. Ophthalmology. 1991;98(3):287–295. doi:10.1016/S0161-6420(91)32298-X.
- Chang JW, Kim JH, Kim S-J, Yu YS. Long-term clinical course and visual outcome associated with Peters’ anomaly. Eye. 2012;26(9):1237–1242. doi:10.1038/eye.2012.128.
- Yang LL, Lambert SR, Lynn MJ, Stulting RD. Long-term results of corneal graft survival in infants and children with peters anomaly. Ophthalmology. 1999;106(4):833–848. doi:10.1016/S0161-6420(99)90175-6.
- Aasuri MK, Garg P, Gokhle N, Gupta S. Penetrating keratoplasty in children. Cornea. 2000;19(2):140–144. doi:10.1097/00003226-200003000-00004.
- Yoshikawa H, Sotozono C, Ikeda Y, Mori K, Ueno M, Kinoshita S. Long-term clinical course in eyes with peters anomaly. Cornea. 2017;36(4):448–451. doi:10.1097/ICO.0000000000001161.
- Choe S, Yoon CH, Kim MK, Hyon JY, Yu YS, Oh JY. Spontaneous regression of congenital corneal opacity. Graefes Arch Clin Exp Ophthalmol. 2020;258(2):359–366. doi:10.1007/s00417-019-04526-5.
- Spierer O, Cavuoto KM, Suwannaraj S, McKeown CA, Chang TC. Outcome of optical iridectomy in Peters anomaly. Graefes Arch Clin Exp Ophthalmol. 2018;256(9):1679–1683. doi:10.1007/s00417-018-4000-2.
- Zaidman GW, Rabinowitz Y, Forstot SL. Optical iridectomy for corneal opacities in Peter’s anomaly. J Cataract Refract Surg. 1998;24(5):719–722. doi:10.1016/S0886-3350(98)80272-1.
- Maharana PK, Jhanji V, Vajpayee RB. Penetrating corneal grafts for infantile corneal opacity: a waste of time? Expert Rev Ophthalmol. 2015;10(4):325–327. doi:10.1586/17469899.2015.1058710.
- Vanathi M, Panda A, Vengayil S, Chaudhuri Z, Dada T. Pediatric keratoplasty. Surv Ophthalmol. 2009;54(2):245–271. doi:10.1016/j.survophthal.2008.12.011.
- Al-Ghamdi A, Al-Rajhi A, Wagoner MD. Primary pediatric keratoplasty: indications, graft survival, and visual outcome. J AAPOS. 2007;11(1):41–47. doi:10.1016/j.jaapos.2006.09.012.
- McClellan K, Lai T, Grigg J, Billson F. Penetrating keratoplasty in children: visual and graft outcome. Br J Ophthalmol. 2003;87(10):1212–1214. doi:10.1136/bjo.87.10.1212.
- Stulting RD, Sumers KD, Cavanagh HD, Waring GO, Gammon JA. Penetrating keratoplasty in children. Ophthalmology. 1984;91(10):1222–1230. doi:10.1016/S0161-6420(84)34171-9.
- Beauchamp GR. Pediatric keratoplasty: problems in management. J Pediatr Ophthalmol Strabismus. 1979;16(6):388–394. doi:10.3928/0191-3913-19791101-13.
- Gollamudi SR, Traboulsi EI, Chamon W, Stark WJ, Maumenee IH. Visual outcome after surgery for Peters’ anomaly. Ophthalmic Genet. 1994;15(1):31–35. doi:10.3109/13816819409056908.
- Rao KV, Fernandes M, Gangopadhyay N, Vemuganti GK, Krishnaiah S, Sangwan VS. Outcome of penetrating keratoplasty for Peters anomaly. Cornea. 2008;27(7):749–753. doi:10.1097/ICO.0b013e31816fe9a7.
- Sun Y, Lin Q, Miao S, Wang W, Pan Z. Analysis of graft failure after primary penetrating keratoplasty in children with peters anomaly. Cornea. 2020;39(8):961–967. doi:10.1097/ICO.0000000000002331.
- Zaidman GW, Flanagan JK, Furey CC. Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. Am J Ophthalmol. 2007;144(1):104–108. doi:10.1016/j.ajo.2007.03.058.
- Comer RM, Daya SM, O’Keefe M. Penetrating keratoplasty in infants. J AAPOS. 2001;5(5):285–290. doi:10.1067/mpa.2001.117568.
- Dana MR, Schaumberg DA, Moyes AL, Gomes JA. Corneal transplantation in children with Peters anomaly and mesenchymal dysgenesis. Multicenter Pediatric Keratoplasty Study. Ophthalmology. 1997;104(10):1580–1586. doi:10.1016/S0161-6420(97)30093-1.
- Elbaz U, Strungaru H, Mireskandari K, Stephens D, Ali A. Long-term visual outcomes and clinical course of patients with peters anomaly. Cornea. 2021;40(7):822–830. doi:10.1097/ICO.0000000000002577.
- Donoso Rojas R, Jara Urrutia G, López Garin JP. Long-term experience and visual acuity outcomes in patients with peters anomaly. J Pediatr Ophthalmol Strabismus. 2021;58(5):304–310. doi:10.3928/01913913-20210412-01.
- Medsinge A, Speedwell L, Nischal KK. Defining success in infant penetrating keratoplasty for developmental corneal opacities. Am Orthopt J. 2014;64(1):81–88. doi:10.3368/aoj.64.1.81.
- Fouzdar-Jain S, Ibrahim Z, Reitinger J, Cao D, Mocan MC. Visual outcomes in pediatric patients with peters anomaly. Clin Ophthalmol Auckl NZ. 2021;15:2591–2596. doi:10.2147/OPTH.S302299.
- Basdekidou C, Dureau P, Edelson C, De Laage De Meux P, Caputo G. Should unilateral congenital corneal opacities in Peters’ anomaly be grafted. Eur J Ophthalmol. 2011;21(6):695–699. doi:10.5301/EJO.2011.6317.
- Najjar DM, Christiansen SP, Bothun ED, Summers CG. Strabismus and amblyopia in bilateral Peters anomaly. J AAPOS. 2006;10(3):193–197. doi:10.1016/j.jaapos.2006.01.006.
- Dolezal KA, Besirli CG, Mian SI, Sugar A, Moroi SE, Bohnsack BL. Glaucoma and cornea surgery outcomes in peters anomaly. Am J Ophthalmol. 2019;208:367–375. doi:10.1016/j.ajo.2019.08.012.
- Reinhard T, Kallmann C, Cepin A, Godehardt E, Sundmacher R. The influence of glaucoma history on graft survival after penetrating keratoplasty. Graefes Arch Clin Exp Ophthalmol. 1997;235(9):553–557. doi:10.1007/BF00947083.
- Irvine AR, Kaufman HE. Intraocular pressure following penetrating keratoplasty. Am J Ophthalmol. 1969;68(5):835–844. doi:10.1016/0002-9394(69)94577-2.
- The Collaborative Corneal Transplantation Studies Research Group. Design and methods of The Collaborative Corneal Transplantation Studies. Cornea. 1993;12(2):93–103. doi:10.1097/00003226-199303000-00001.
- Wu S, Xu J, Ahmad A. Incidence and risk factors for post-penetrating keratoplasty glaucoma: a systematic review and meta-analysis. PloS One. 2017;12(4):e0176261. doi:10.1371/journal.pone.0176261.
- Baltaziak M, Chew HF, Podbielski DW, Ahmed IIK. Glaucoma after corneal replacement. Surv Ophthalmol. 2018;63(2):135–148. doi:10.1016/j.survophthal.2017.09.003.
- Yang LLH, Lambert SR, Lynn MJ, Stulting RD. Surgical management of glaucoma in infants and children with Peters’ anomaly: long-term structural and functional outcome. Ophthalmology. 2004;111(1):112–117. doi:10.1016/j.ophtha.2003.02.002.
- Beauchamp GR, Knepper PA. Role of the neural crest in anterior segment development and disease. J Pediatr Ophthalmol Strabismus. 1984;21(6):209–214. doi:10.3928/0191-3913-19841101-03.
- Jullienne R, Manoli P, Tiffet T, et al. Corneal endothelium self-healing mathematical model after inadvertent descemetorhexis. J Cataract Refract Surg. 2015;41(10):2313–2318. doi:10.1016/j.jcrs.2015.10.043.
- Ohkawa K, Saika S, Hayashi Y, Tawara A, Ohnishi Y. Cornea with Peters’ anomaly: perturbed differentiation of corneal cells and abnormal extracellular matrix in the corneal stroma. Jpn J Ophthalmol. 2003;47(4):327–331. doi:10.1016/S0021-5155(03)00072-8.
- Joyce NC. Proliferative capacity of corneal endothelial cells. Exp Eye Res. 2012;95(1):16–23. doi:10.1016/j.exer.2011.08.014.
- Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000;41:660–667.
- Soh YQ, Peh G, George BL, et al. Predicative factors for corneal endothelial cell migration. Invest Ophthalmol Vis Sci. 2016;57(2):338–348. doi:10.1167/iovs.15-18300.
- Soh YQ, Mehta JS. Selective endothelial removal for peters anomaly. Cornea. 2018;37(3):382–385. doi:10.1097/ICO.0000000000001472.
- Lin Q, Li L, Sun Y, et al. Penetrating keratoplasty in infants with peters anomaly: visual and graft outcomes. Cornea. 2021;40(6):720–725. doi:10.1097/ICO.0000000000002669.